Safety and Efficacy of One Dose Prophylactic Antibiotic in Laparoscopic Colorectal Surgery

Phase 2CompletedNCT01220661

National Cancer Center, Korea312 enrolled

Overview

In colorectal surgery, the use of prophylactic antibiotics is recommended. The standard use of antibiotics for colorectal surgery is three doses. It has been reported that the surgical site infection rates of laparoscopic colorectal surgery are lower than open colorectal surgery. However, the evidence of proper application of antibiotic for laparoscopic colorectal surgery is still not enough. The investigators are researching the efficacy and safety of one dose prophylactic antibiotic in laparoscopic colorectal surgery.

In colorectal surgery, the use of prophylactic antibiotics is recommended. The standard use of antibiotics for colorectal surgery is three doses. One randomized controlled study reported that surgical site infection rates of three doses prophylactic antibiotics are lower than those of one dose in colorectal surgery (4.3 versus 14.2%). But, surgical site infection rates between one dose and three doses were not different in laparoscopic subgroup of this study (11 versus 11%) It has been reported that the surgical site infection rates of laparoscopic colorectal surgery are lower than open colorectal surgery. However, the evidence of proper application of antibiotic for laparoscopic colorectal surgery is still not enough. The investigators are researching the efficacy and safety of one dose prophylactic antibiotic in laparoscopic colorectal surgery.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

312

Conditions

Colorectal Surgery

Interventions

CefotetanDRUG

preoperative one dose prophylactic antibiotic (2g iv, within 1 hour before skin incision)

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients have laparoscopic colorectal surgery for cancer at National Cancer Center * Patients should sign a written informed consent * Age between 18-80 years * Adequate bone marrow function Hb ≥ 10g/dl (after treatment for simple iron deficiency anemia) WBC ≥ 3,000/mm3 PLT ≥ 100,000/mm3 * Adequate kidney function Creatinine ≤ 1.5 mg/dl * No remarkable evidence of heart dysfunction and lung dysfunction Exclusion Criteria: * Patients undergo emergency surgery with multiple symptoms * Open colorectal surgery for cancer or conversion to an open procedure * Patients who undergo only ostomy surgery * Palliative surgery * Surgery combined with other organs * Patients on treatment with recurred cancer * Patients who have active bacterial infection and required parenteral antibiotics * Patients have an allergy to Cefoxitin * Other organ cancer history(except who had radical excision for skin cancer) * Presence of other serious disease * Mentally ill patients * Legally unable to participate in clinical trial * Lactating or pregnant women * Patients who will obviously fail to regular follow-up visit or will be off study voluntarily * Not eligible to participate for other reasons by doctor's decision

Locations (1)

National Cancer Center Hospital

Goyang-si, Gyeonggi-do, South Korea

Outcomes

Primary Outcomes

Surgical site infection

any surgical infections (superficial incisional infection or infection of deep incision space or organ space infection)

Time frame: Three weeks after surgery

Secondary Outcomes

Overall infection

Overall infection including surgical site infection, pneumonia, urinary tract infection etc.

Time frame: Three weeks after surgery

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.